195. El-Cheikh, J., Faucher, C., Furst, S., Duran, S., Berger, P., Vey, N., Stoppa, A. M., Bouabdallah, R., Gastaut, J. A., Viens, P., Blaise, D., and Mohty, M. High-dose weekly liposomal amphotericin B antifungal prophylaxis following reducedintensity conditioning allogeneic stem cell transplantation Bone Marrow Transplantation,2007; Vol. 39 (5) : 301-306. 196. Etienne, A., Gelsi-Boyer, V., Carbuccia, N., Adelaide, J., Barba, G., La, Starza R., Murati, A., Eclache, V., Birg, F., Birnbaum, D., Mozziconacci, M. J., Mecucci, C., and Chaffanet, M. Combined translocation with ZNF198-FGFR1 gene fusion and deletion of potential tumor suppressors in a myeloproliferative disorder Cancer Genetics and Cytogenetics,2007; Vol. 173 (2) : 154-158. 197. Etienne, A., Esterni, B., Charbonnier, A., Mozziconacci, M. J., Arnoulet, C., Coso, D., Puig, B., Gastaut, J. A., Maraninchi, D., and Vey, N. Comorbidity is an independent predictor of complete remission in elderly patients receiving induction chemotherapy for acute myeloid leukemia Cancer,2007; Vol. 109 (7) : 1376-1383. 198. Etienne, A., Carbuccia, N., Adelaide, J., Bekhouche, I., Remy, V., Sohn, C., Sainty, D., Gastaut, J. A., Olschwang, S., Birnbaum, D., Mozziconacci, M. J., and Chaffanet, M. Rearrangements involving 12q in myeloproliferative disorders: possible role of HMGA2 and SOCS2 genes Cancer Genetics and Cytogenetics,2007; Vol. 176 (1) : 80-88. 199. Fabre-Lafay, S., Monville, F., Garrido-Urbani, S., Berruyer-Pouyet, C., Ginestier, C., Reymond, N., Finetti, P., Sauvan, R., Adelaide, J., Geneix, J., Lecocq, E., Popovici, C., Dubreuil, P., Viens, P., Goncalves, A., Charafe-Jauffret, E., Jacquemier, J., Birnbaum, D., and Lopez, M. Nectin-4 is a new histological and serological tumor associated marker for breast cancer BMC Cancer,2007; Vol. 7 (73- 200. Fauriat, C., Just-Landi, S., Mallet, F., Arnoulet, C., Sainty, D., Olive, D., and Costello, R. T. Deficient expression of NCR in NK cells from acute myeloid leukemia: evolution during leukemia treatment and impact of leukemic cells in NCRdull phenotype induction Blood,2007; Vol. 109 (1) : 323-330. 201. Filaci, G., Fenoglio, D., Fravega, M., Ansaldo, G., Borgonovo, G., Traverso, P., Villaggio, B., Ferrera, A., Kunkl, A., Rizzi, M., Ferrera, F., Balestra, P., Ghio, M., Contini, P., Setti, M., Olive, D., Azzarone, B., Carmignani, G., Ravetti, J. L., Torre, G., and Indiveri, F. CD8+CD28 T Regulatory Lymphocytes Inhibiting T Cell Proliferative and Cytotoxic Functions Infiltrate Human Cancers Journal of Immunology,2007; Vol. 179 (7) : 4323-4334.
202. Gallina, A., Karakiewicz, P. I., Hutterer, G. C., Chun, F. K., Briganti, A., Walz, J., Antebi, E., Shariat, S. F., Suardi, N., Graefen, M., Erbersdobler, A., Salonia, A., Rigatti, P., Huland, H., and Montorsi, F. Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European men International Journal of Cancer,2007; Vol. 121 (4) : 791-795. 203. Gallina, A., Jeldres, C., Chun, F. K., Shariat, S. F., Briganti, A., Walz, J., Roehrborn, C. G., Saad, F., Huland, H., Graefen, M., Montorsi, F., and Karakiewicz, P. I. Prediction of pathological stage is inaccurate in men with PSA values above 20 ng/mL European Urology,2007; Vol. 52 (5) : 1374-1380. 204. Gallina, A., Karakiewicz, P. I., Chun, F. K., Briganti, A., Graefen, M., Montorsi, F., Walz, J., Jeldres, C., Erbersdobler, A., Salonia, A., Suardi, N., Deho, F., Schlomm, T., Scattoni, V., Haese, A., Heinzer, H., Valiquette, L., Rigatti, P., and Huland, H. Health-insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancer BJU International,2007; Vol. 99 (6) : 1404-1408. 205. Gallina, A., Briganti, A., Chun, F. K., Walz, J., Hutterer, G. C., Erbersdobler, A., Eichelberg, C., Schlomm, T., Ahyai, S. A., Perrotte, P., Saad, F., Montorsi, F., Huland, H., Graefen, M., and Karakiewicz, P. I. Effect of autologous blood transfusion on the rate of biochemical recurrence after radical prostatectomy BJU International,2007; Vol. 100 (6) : 1249-1253. 206. Garay, R. P., Viens, P., Bauer, J., Normier, G., Bardou, M., Jeannin, J. F., and Chiavaroli, C. Cancer relapse under chemotherapy: why TLR2/4 receptor agonists can help European Journal of Pharmacology,2007; Vol. 563 (1-3) : 1-17. 207. Garcia, S., Dales, J. P., Jacquemier, J., Charafe-Jauffret, E., Birnbaum, D., Andrac-Meyer, L., Lavaut, M. N., Allasia, C., Carpentier-Meunier, S., Bonnier, P., and Charpin-Taranger, C. c-Met overexpression in inflammatory breast carcinomas: automated quantification on tissue microarrays British Journal of Cancer,2007; Vol. 96 (2) : 329-335. 208. Garcia, S., Dales, J. P., Charafe-Jauffret, E., Carpentier-Meunier, S., Andrac- Meyer, L., Jacquemier, J., Andonian, C., Lavaut, M. N., Allasia, C., Bonnier, P., and Charpin, C. Overexpression of c-Met and of the transducers PI3K, FAK and JAK in breast carcinomas correlates with shorter survival and neoangiogenesis International Journal of Oncology,2007; Vol. 31 (1) : 49-58. 209. Garcia, S., Dales, J. P., Charafe-Jauffret, E., Carpentier-Meunier, S., Andrac- Meyer, L., Jacquemier, J., Andonian, C., Lavaut, M. N., Allasia, C., Bonnier, P., and Charpin, C. Poor prognosis in breast carcinomas correlates with increased expression of targetable CD146 and c-Met and with proteomic basal-like phenotype Humam Pathology,2007; Vol. 38 (6) : 830-841.
- Page 1 and 2: PUBLICATIONS IPC 2006-2010 1. Adeka
- Page 3 and 4: 20. Bertucci, F., Viens, P., and Bi
- Page 5 and 6: 37. Castellano, R., Vire, B., Pion,
- Page 7 and 8: 52. De Lavallade, H., Mohty, M., Fa
- Page 9 and 10: 70. Fieulaine N, Apostolidis T, Oli
- Page 11 and 12: 89. Girard, N., Mornex, F., Partens
- Page 13 and 14: 105. Huiart, L., Ernst, P., Ranouil
- Page 15 and 16: 122. Le Ber, I, Guedj, E., Gabelle,
- Page 17 and 18: 138. Mohty, M., Nagler, A., and Kil
- Page 19 and 20: 157. Popovici, C., Fallet, M., Marg
- Page 21 and 22: 172. Turrini, O., Moutardier, V., G
- Page 23: 183. Adelaide, J., Finetti, P., Bek
- Page 27 and 28: 220. Gravis, G., Salem, N., Bladou,
- Page 29 and 30: 237. Lecine, P., Esmiol, S., Metais
- Page 31 and 32: 256. Blaise, D., Vey, N., Faucher,
- Page 33 and 34: 273. Charafe-Jauffret, E., Mrad, K.
- Page 35 and 36: 289. Dany L, Apostolidis T. Approch
- Page 37 and 38: 306. Lhomme, C., Planchamp, F., Jol
- Page 39 and 40: 323. Moatti, J. P. Oncogériatrie,
- Page 41 and 42: 343. Patenaude, A. F. and Julian-Re
- Page 43 and 44: 361. Schlomm, T., Kirstein, P., Iwe
- Page 45 and 46: 378. Turrini, O., Viret, F., Mourea
- Page 47 and 48: 392. Abu-Zaineh, M., Mataria, A., L
- Page 49 and 50: 407. Bali L, Cuisset T, Giorgi R, M
- Page 51 and 52: 427. Buecher, B., Baert-Desurmont,
- Page 53 and 54: 443. Chetaille, B. and Xerri, L. Pi
- Page 55 and 56: 460. Dijon, M., Chabannon, C., and
- Page 57 and 58: 480. Fenoglio, D., Ferrera, F., Fra
- Page 59 and 60: 496. Gravis, G., Bladou, F., Salem,
- Page 61 and 62: 513. Kelaidi, C., Park, S., Brechig
- Page 63 and 64: 530. Lert F, Sitta R, Dray-Spira R,
- Page 65 and 66: 546. Mancini J, Rey D, Préau M. L
- Page 67 and 68: 565. Moreau, P., Garban, F., Attal,
- Page 69 and 70: 582. Pellegrini I. Elle n’accepte
- Page 71 and 72: 601. Rey, J., Xerri, L., Bouabdalla
- Page 73 and 74: 617. Sztark, F., Francon, D., Combe
- Page 75 and 76:
634. Walz, J., Shariat, S. F., Suar
- Page 77 and 78:
650. Barbier, L. A "cystic" lesion
- Page 79 and 80:
669. Blaise D, Tabrizi R, Michallet
- Page 81 and 82:
685. Carbuccia, N., Murati, A., Tro
- Page 83 and 84:
701. Deville JL, Bartoli C, Kaafara
- Page 85 and 86:
719. Gaudart J, Giorgi R, Fieschi M
- Page 87 and 88:
734. Houvenaeghel, G., Nos, C., Gia
- Page 89 and 90:
750. Kantarjian, H. M., Larson, R.
- Page 91 and 92:
766. Mataria, A., Khatib, R., Donal
- Page 93 and 94:
783. Peretti-Watel, P., Seror, V.,
- Page 95 and 96:
800 Rey D, Ben Diane MK, Viens P, B
- Page 97 and 98:
818 Shagdarsuren, E., Djalali-Talab
- Page 99 and 100:
834 Turrini, O., Viret, F., Moureau
- Page 101 and 102:
848 Acquaviva, C., Gelsi-Boyer, V.,
- Page 103 and 104:
865 Belot A, Abrahamowicz M, Remont
- Page 105 and 106:
882 Chabannon, C., Honstettre, A.,
- Page 107 and 108:
898 Courbiere, B., Prebet, T., Mozz
- Page 109 and 110:
914 Filleron, T., Laplanche, A., Bo
- Page 111 and 112:
932 Hannoun-Levi, J. M., Ortholan,
- Page 113 and 114:
941 Jeanniard-Malet, O., Gravis, G.
- Page 115 and 116:
959 Lecuru, F., Huchon, C., Metzger
- Page 117 and 118:
978 Moatti, J. P. and Eboko, F. Eco
- Page 119 and 120:
994 Out, A. A., Tops, C. M., Nielse
- Page 121 and 122:
1009 Reynolds, L. E., Watson, A. R.
- Page 123 and 124:
1024 Salmi-Smail, C., Fabre, A., De
- Page 125 and 126:
1041 Taïeb D, Sebag F, Farman-Ara